Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019270 (
hernia
)
15,856
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
BMP4
loss-of-function mutations and deletions have been shown to be associated with ocular, digital, and brain anomalies, but due to the paucity of these reports, the full phenotypic spectrum of human
BMP4
mutations is not clear. We screened 133 patients with a variety of ocular disorders for
BMP4
coding region mutations or genomic deletions.
BMP4
deletions were detected in two patients: a patient affected with SHORT syndrome and a patient with anterior segment anomalies along with craniofacial dysmorphism and cognitive impairment. In addition to this, three intragenic
BMP4
mutations were identified. A patient with anophthalmia, microphthalmia with sclerocornea, right-sided diaphragmatic
hernia
, and hydrocephalus was found to have a c.592C >T (p.R198X) nonsense mutation in
BMP4
. A frameshift mutation, c.171dupC (p.E58RfsX17), was identified in two half-siblings with anophthalmia/microphthalmia, discordant developmental delay/postaxial polydactyly, and poor growth as well as their unaffected mother; one affected sibling carried an additional
BMP4
mutation in the second allele, c.362A > G (p.H121R). This is the first report indicating a role for
BMP4
in SHORT syndrome, Axenfeld-Rieger malformation, growth delay, macrocephaly, and diaphragmatic
hernia
. These results significantly expand the number of reported loss-of-function mutations, further support the critical role of
BMP4
in ocular development, and provide additional evidence of variable expression/non-penetrance of
BMP4
mutations.
...
PMID:BMP4 loss-of-function mutations in developmental eye disorders including SHORT syndrome. 2134 Jun 93